Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest

Cancer Research

Volumn 58, Issue 14, 1998, Pages 3163-3172

  Yen, Andrew ^a   Roberson, Mark S ^a   Varvayanis, Susi ^a   Lee, Amy T ^a  

^a Cancer Biology Laboratory Department of Pathology Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; RETINOBLASTOMA PROTEIN; RETINOIC ACID; RETINOID X RECEPTOR;

ARTICLE; CANCER GROWTH; CELL CYCLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

EID: 0032528172     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Gudas, L. J. Retinoids and vertebrate development. J. Biol. Chem., 22: 15399-15402, 1994.
2. Mangelsdorf, D. J., Kazukiko, U., and Evans, R. M. The retinoid receptors. In: M. B. Sporn, A. Roberts, and D. S. Goodman (eds.), The Retinoids, 2nd ed., pp. 319-349. New York: Raven Press, 1994.
3. Kamie, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S-C., Heyman, R. A., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85: 403-414, 1996.
4. Kizaki, M., Dawson, M. I., Heyman, R., Elstner, E., Morosetti, R., Pakkala, S., Chen, D. L., Ueno, H., Chao, W. R., Morikawa, M., Ikeda, Y., Heber, D., Pfahl, M., and Koeffler, H. P. Effects of novel retinoid X receptor-selective ligands on myeloid leukemic differentiation and proliferation in vitro. Blood, 87: 1977-1984, 1996.
5. Chen, J. Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E., Reczek, P., Chambon, P., and Gronemeyer, H. RAR-specific agonist-antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J., 14: 1187-1197, 1995.
6. Fanjul, A., Dawson, M. L., Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X. P., and Pfahl, M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (Lond.), 372: 107-111, 1994.
7. Hopkins, K. Spools, switches, or scaffolds: how might histones regulate transcription? J. NIH Res., 9: 34-37, 1997.
8. Pazin, M. J., and Kadonaga, J. T. What's up and down with histone deacetylation and transcription? Cell, 89: 325-328, 1997.
9. Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., and Evans, R. M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell, 90: 569-580, 1997.
10. Nagy, L., Kao, H-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., and Evans, R. M. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell, 89: 373-380, 1997.
11. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., and Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87: 953-959, 1996.
12. Oridate, N., Suzuki, S., Higuchi, M., Mitchell, M. F., Hong, W. K., and Lotan, R. Involvement of reactive oxygen species in N-(4-hydroxyphenyl) retinamide-induced apoptosis in cervical carcinoma cells. J. Natl. Cancer Inst., 89: 1191-1198, 1997.
13. Takahaski, N., Sausvile, E. A., and Bretiman, T. R. N-(4-Hydroxyphenyl) retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins. Clin. Cancer Res., 1: 637-642, 1995.
14. Takahaski, N., and Bretiman, T. R. Retinoylation of vimentin in the human myeloid leukemia cell line HL-60. J. Biol. Chem., 269: 5913-5917, 1994.
15. Han, G. R., Dohi, D. F., Lee, H. Y., Rajah, R., Walsh, G. L., Hong, W. K., Cohen, P., and Kurie, J. M. All-trans-retinoic acid increases transforming growth factor-β2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-α-dependent signaling pathway. J. Biol. Chem., 272: 13711-13716, 1997.
16. Nunes, I., Kojima, S., and Rifkin, D. B. Effects of endogenously activated transforming growth factor β on growth and differentiation of retinoic acid-treated HL-60 cells. Cancer Res., 56: 495-499, 1996.
17. Turley, J. M., Falk, L. A., Ruscetti, F. W., Kasper, J. J., Francomano, T., Fu, T., Bang, O. S., and Birchenall-Roberts, M. C. Transforming growth factor β1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. Cell Growth Differ., 7: 1535-1544, 1996.
18. Hembree, J. R., Agarwal, C., Beard, R. L., Chandraratna, R. A. S., and Eckert, R. L. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein 3 in human ectocervical epithelial cells. Cancer Res., 56: 1794-1799, 1996.
19. Danielpour, D. Induction of transforming growth factor β autocrine activity by all-trans-retinoic acid and 1α,25-dihydroxyvitamin D-3 in NRP-152 rat prostatic epithelial cells. J. Cell. Physiol, 166: 231-239, 1996.
20. Cohen, P. S., Letterio, J. J., Gaetano, C., Chan, J., Matsumoto, K., Sporn, M. B., and Thiele, C. J. Induction of transforming growth factor β1 and its receptor during all-trans-retinoic (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res., 55: 2380-2386, 1995.
21. Yen, A. HL-60 cells as a model of growth control and differentiation: the significance of variant cells. Hematol. Rev., 4: 5-46, 1990.
22. Collins, S. J., Gallo, R. C., and Gallagher, R. E. Continuous growth and differentiation lineage specificity: continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (Lond.), 270: 347-349, 1977.
23. Yen, A., Forbes, M., deGala, G., and Fishbaugh, J. Control of HL-60 cell differentiation lineage specificity: a late event occurring after precommitment. Cancer Res., 47: 129-134, 1987.
24. Yen, A., Powers, V., and Fishbaugh, J. Retinoic acid induced HL-60 myeloid differentiation: dependence of early and late events on isomeric structure. Leuk. Res., 10: 619-629, 1986.
25. Yen, A., Reece, S. L., and Albright, K. L. Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: pre-commitment memory associated with altered nuclear structure. J. Cell. Physiol., 118: 277-286, 1984.
26. Yen, A., Sturgill, R., and Varvayanis, S. Increasing C-FMS expression decreases retinoic acid concentration needed to cause cell differentiation and RB hypophosphorylation. Cancer Res., 57: 2020-2028, 1997.
27. 1 arrest and cell differentiation. Exp. Cell Res., 229: 111-125, 1996.
28. Rohrschneider, L. R. The macrophage colony-stimulating factor (M-CSF) receptor. In: Guidebook to Cytokines and Their Receptors, pp. 168-170. New York: Oxford University Press, 1994.
29. Sherr, C. J. The colony-stimulating factor 1 receptor: pleiotropy of signal-response coupling. Lymphokine Res., 9: 543-548, 1990.
30. Cooper, G. M. Pathways of mitogenic signal transduction. In: Oncogenes, 2nd ed., pp. 279-306. Boston and London: Jones and Bartlett Publishers, 1995.
31. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D., and Chambon, P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science (Washington DC), 270: 1491-1949, 1995.
32. Bunone, G., Briand, P. A., Miksicek, R. J., and Picard, D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J., 15: 2174-2183, 1996.
33. Watters, J. J., Campbell, J. S., Cunningham, M. J., Krebs, E. G., and Dorsa, D. M. Rapid membrane effects of steroids in neuroblastoma cells: effect of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology, 138: 4030-4033, 1997.
34. Endoh, H., Sasaki, H., Maruyama, K., Takeyama, K. I., Waga, I., Shimizu, T., Kato, S., and Kawashima, H. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem. Biophys. Res. Commun., 235: 99-102, 1997.
35. Matkovits, T., and Christakos, S. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. Mol. Endocrinol., 9: 232-242, 1995.
36. Flicker, S. H., Schneider, S. M., Offterdinger, M., Dittrich, E., Fazeny, B., Valenta, R., Huber, H., Dittrich, C., and Grunt, T. W. Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-α in SK-BR-3 breast cancer cells. Cancer Lett., 115: 63-72, 1997.
37. Brooks, S. C., III, Kazmer, S., Levin, A. A., and Yen, A. Myeloid differentiation and RB phosphorylation changes in HL-60 cells induced by RAR-and RXR-selective retinoic acid analogs. Blood, 87: 227-237, 1996.
38. Yen, A., Chandler, S., Forbes, M. E., Fung, Y-K., T'Ang, A., and Pearson, R. Coupled down-regulation of the RB retinoblastoma and C-MYC genes antecedes cell differentiation: possible role of RB as a "status quo" gene. Eur. J. Cell Biol., 57: 210-221, 1992.
39. Yen, A., Forbes, M. E., Varvayanis, S., Tykocinski, M. L., Groger, R. K., and Platko, J. D. C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression. J. Cell. Physiol., 157: 379-391, 1993.
40. Gaub, M. P., Rochette-Egly, C, Lutz, Y., Ali, S., Matthes, H., Scheuer, I., and Chambon, P. Immunodetection of multiple species of retinoic acid receptor α: evidence for phosphorylation. Exp. Cell Res., 201: 335-346, 1992.
41. Roberson, M. S., Misra-Press, A., Laurance, M. E., Stork, P. J. S., and Maurer, R. A. A role for mitogen activated protein kinase in mediating activation of the glycoprotein hormone α-subunit promoter by gonadotropin-releasing hormone. Mol. Cell. Biol., 15: 3531-3539, 1995.
42. Smith, D. B., and Johnson, K. S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (Amst.), 67: 31-40, 1988.
43. Petkovich, M., Brand, N. J., Krust, A., and Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (Lond.), 330: 444-450, 1987.
44. Green, S., Issemann, I., and Sheer, E. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res., 16: 369, 1988.
45. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., and Saltiel, A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA, 92: 7686-7689, 1995.
46. 2 during the process of induced cell differentiation. Exp. Cell Res., 214: 250-257, 1994.
47. Yen, A., Coder, D., and Varvayanis, S. Concentration of RB protein in nucleus versus cytoplasm is stable as phosphorylation of RB changes during the cell cycle and differentiation. Eur. J. Cell Biol., 72: 159-165, 1997.
48. Yen, A., Williams, M., Platko, J. D., Der, C., and Hisaka, M. Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation. Eur. J. Cell Biol., 65: 103-113, 1994.
49. Kim, B., Leventhal, P. S., Saltiel, A. R., and Feldman, E. L. Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation. J. Biol. Chem., 272: 21268-21273, 1997.
50. Pang, L., Sawada, T., Decker, S. J., and Saltiel, A. R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem., 270: 13585-13588, 1995.
51. Gomez, N., and Cohen, P. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature (Lond.), 353: 170-173, 1991.
52. Biggs, W. H., III, Zavitz, K. H., Dickson, B., Van Der Straten, A., Brunner, D., Hafen, E., and Zipursky, S. L. The Drosophila rolled locus encodes a MAP kinase required in the sevenless signal transduction pathway. EMBO J., 13: 1628-1635, 1994.
53. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80: 179-185, 1995.
54. Traverse, S., Gomez, N., Paterson, H., Marshall, C., and Cohen, P. Sustained activation of the mitogen-activated protein MAP kinase cascade may be required for differentiation of PC12 cells comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J., 288: 352-355, 1992.
55. Fisher, T. L., and Blenis, J. Evidence for two catalytically active kinase domains in pp90-rsk. Mol. Cell. Biol., 16: 1212-1219, 1996.
56. Kharbanda, S., Saleem, A., Hirano, M., Emoto, Y., Sukhatme, V., Blenis, J., and Kufe, D. Activation of early growth response 1 gene transcription and pp90-rsk during induction of monocytic differentiation. Cell Growth Differ., 5: 259-265, 1994.
57. Sewing, A., Wiseman, B., Lloyd, A-C., and Land, H. High-intensity RAF signal causes cell cycle arrest mediated by p21-Cipl. Mol. Cell. Biol., 17: 5588-5597, 1997.
58. Lioubin, M. N., Myles, G. M., Carlberg, K., Bowtell, D., and Rohrschneider, L. R. Shc, Grb2, Sos1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells. Mol. Cell. Biol., 14: 5682-5691, 1994.